Prosecution Insights
Last updated: September 17, 2026
Application No. 18/596,175

BIOMONOMERS AND THEIR RESPECTIVE BIOPOLYMERS FOR PAINTS AND VARNISHES

Non-Final OA §112
Filed
Mar 05, 2024
Priority
Mar 01, 2024 — BR 10 2024 004247 6
Examiner
CUTLIFF, YATE KAI RENE
Art Unit
Tech Center
Assignee
Nuol Green Chemistry LLC
OA Round
1 (Non-Final)
80%
Grant Probability
Favorable
1-2
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 80% — above average
80%
Career Allowance Rate
1038 granted / 1301 resolved
+19.8% vs TC avg
Strong +24% interview lift
Without
With
+24.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 2m
Avg Prosecution
35 currently pending
Career history
1316
Total Applications
across all art units

Statute-Specific Performance

§101
3.9%
-36.1% vs TC avg
§103
38.6%
-1.4% vs TC avg
§102
13.1%
-26.9% vs TC avg
§112
34.4%
-5.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1301 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Clams 1 – 8 are pending. Claims 1 – 8 are rejected. Drawings The drawings are objected to as failing to comply with 37 CFR 1.84(p)(5) because they include the following reference character(s) not mentioned in the description: “R1” in Figures 3 and 4. Corrected drawing sheets in compliance with 37 CFR 1.121(d), or amendment to the specification to add the reference character(s) in the description in compliance with 37 CFR 1.121(b) are required in reply to the Office action to avoid abandonment of the application. Any amended replacement drawing sheet should include all of the figures appearing on the immediate prior version of the sheet, even if only one figure is being amended. Each drawing sheet submitted after the filing date of an application must be labeled in the top margin as either “Replacement Sheet” or “New Sheet” pursuant to 37 CFR 1.121(d). If the changes are not accepted by the examiner, the applicant will be notified and informed of any required corrective action in the next Office action. The objection to the drawings will not be held in abeyance. Specification The specification is objected to as failing to provide proper antecedent basis for the claimed subject matter. See 37 CFR 1.75(d)(1) and MPEP § 608.01(o). Correction of the following is required: Figures 3 and 4 reference “R1”. There is no support in the disclosure for substituent “R1” in the current figures 3 and 4. Claim Objections Claims 1 – 8 are objected to because of the following informalities: Claim 1 should begin “A process…”; and claims 2 – 8 should begin with “The process…” because they are dependent claims. Appropriate correction is required. Claim 1 is objected for making reference to Figures 2, and 4 in the claim. here possible, claims are to be complete in themselves. Incorporation by reference to a specific figure or table "is permitted only in exceptional circumstances where there is no practical way to define the invention in words and where it is more concise to incorporate by reference than duplicating a drawing or table into the claim. In this instance there was a practical way to define the chemical structures in the claim. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. Claims 1- 8 are rejected under 35 U.S.C. 112(b), as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, regards as the invention. Claims 1 – 8 are rendered indefinite for containing both process of making and process of use limitations in the same claim. The claims is ambiguous because it is not clear from claim 1 what the focus of the claim should be the process of making the chemicals of figures 2, 3 and 4 or the process of using the chemicals of figures 2, 3 and 4. In Ex parte Lyell, 17 USPQ2d 1548 (Bd. Pat. App. & Inter. 1990), claim directed to an automatic transmission workstand and the method of using it held ambiguous and properly rejected under 35 USC 112, second paragraph. Regarding claim 4, the phrase "such as" renders the claim indefinite because it is unclear whether the limitations following the phrase are part of the claimed invention. See MPEP § 2173.05(d). Regarding claim 6, the phrase "such as" renders the claim indefinite because it is unclear whether the limitations following the phrase are part of the claimed invention. See MPEP § 2173.05(d). Allowable Subject Matter The compound of Figure 2 appears to be allowable. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to YATE' K. CUTLIFF whose telephone number is (571)272-9067. The examiner can normally be reached Monday-Friday (8:30 - 5:30). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Y. Goon can be reached at (571) 270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /YATE' K CUTLIFF/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

Mar 05, 2024
Application Filed
May 15, 2024
Response after Non-Final Action
Aug 27, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12723014
REMOVAL OF SULFATE FROM MEG STREAMS USING CALCIUM CHLORIDE
2y 1m to grant Granted Sep 01, 2026
Patent 12715683
CONTAINER AND PROCESS FOR THE STORAGE OF A SATURATED ALIPHATIC C6-C12 CARBOXYLIC ACID
3y 4m to grant Granted Aug 25, 2026
Patent 12715835
BIORENEWABLE SYNTHESIS OF HYDROXY-HEXANOATE ESTERS
3y 0m to grant Granted Aug 25, 2026
Patent 12715842
D-LUCIFERIN, D-LUCIFERIN DERIVATIVE, PRECURSOR OF THESE COMPOUNDS AND METHOD FOR PRODUCING THESE COMPOUNDS
2y 11m to grant Granted Aug 25, 2026
Patent 12709591
METHOD FOR PRODUCING ACRYLIC ACID
4y 1m to grant Granted Aug 18, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
80%
Grant Probability
99%
With Interview (+24.3%)
2y 2m (~0m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1301 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month